A2 Milk's China Business Recovers to 50% of Pre-Disruption Levels

By•
A2 Milk's China Business Recovers to 50% of Pre-Disruption Levels

New Zealand-based dairy company The a2 Milk Company has reported a recovery in estimated offtake for its China-label infant milk formula (IMF) to approximately 50% of pre-supply disruption levels, up from around 40% in August 2026.

The improvement signals progress in rebuilding consumer demand following supply shortages that disrupted product availability and prompted some consumers to switch to competing brands.

China Market Recovery Remains Gradual

The company faced supply challenges during 2026 due to low inventories, strong demand and higher freight costs associated with geopolitical tensions in the Middle East.

These disruptions significantly affected China-label infant formula availability during the fourth quarter of FY26, with the impact expected to continue into FY27.

While offtake has improved, the recovery remains incomplete. The company has deliberately restricted distribution to approximately two-thirds of previous levels to support retail sell-through and maintain a healthier trade ecosystem.

Marketing and Product Innovation Drive Recovery

A2 Milk is increasing marketing investments, particularly during the first half of FY27, while introducing new products to strengthen consumer engagement and rebuild market share.

The company expects China-label and English-label infant formula sales to gradually recover during FY27, supported by new product launches and improved product availability.

However, the company expects its financial performance to be heavily weighted towards the second half of FY27, reflecting the slower-than-expected recovery in its China business.

Financial Outlook Remains Cautious

A2 Milk maintained its full-year FY27 revenue growth outlook at mid-single-digit percentage levels, although first-half revenue is now expected to be slightly lower than the corresponding period last year.

The company expects an underlying EBITDA margin of approximately 15% for FY27, with first-half earnings materially lower than the previous corresponding period.

The supply-chain disruption had reduced China-label infant formula revenue by 14% during FY26, while the company's annual net profit declined 44% to NZ$113.6 million.

What This Means for the Dairy Industry

The recovery highlights the vulnerability of premium dairy and infant formula brands to supply-chain disruptions, particularly in highly competitive markets such as China.

For dairy exporters, maintaining consumer loyalty during shortages can be as challenging as restoring product availability. A2 Milk's recovery strategy demonstrates the importance of balancing distribution, inventory management, marketing investment and retail sell-through.

The company's progress will be closely watched by global dairy brands seeking to rebuild market share in China amid changing consumer preferences and competitive pressures.

Source:  Read full story here 20 Nov, 2026 Edited and Reported by

#DairyIndustry #InfantFormula #DairyNews7x7

Never miss an important dairy update

Follow DairyNews7x7 on Google to get live milk prices, policy alerts, and daily headlines directly in your feed.